PJ, June 2016, Vol 296, No 7890

First self-administered monthly injection for multiple sclerosis approved in the US

Zinbryta (daclizumab), the first once-monthly self-administered injection for multiple sclerosis (MS), has been approved by the US Food and Drug Administration.…

EMA approves combination treatment for type 2 diabetes

A new combination therapy that can lower blood glucose levels in patients with type 2 diabetes is being recommended for marketing approval for some patients by the European Medicines Agency (EMA).…

NHS England confirms decision not to fund pre-exposure prophylaxis for HIV

NHS England has reiterated that it will not fund pre-exposure prophylaxis (PrEP) for HIV prevention. This decision was first announced in March 2016, but pressure from stakeholder groups pushed NHS England to convene a meeting of the specialised services commissioning committee to re…

Overcoming the challenges in developing male contraceptives

With several hormonal and non-hormonal male contraceptive candidates in the pipeline, researchers are hoping to ignite interest from a wary pharmaceutical industry.…

PSNC, RPS and Pharmacy Voice to join forces and publish forward view for community pharmacy

Pharmacy bodies are working together to develop their own forward view as government rejects PSNC’s counterproposals to £170m cuts.…

More data needed for ibrutinib before NICE considers its place on cancer drugs fund

For the first time, the National Institute for Health and Care Excellence (NICE) has asked a pharmaceutical company to provide evidence so that its anticancer drug can be considered for inclusion in the cancer drugs fund.…

Counterfeit medicines are a growing threat to global health, WHO meeting hears

Substandard and counterfeit medicines pose a growing threat to global health and greater global efforts are needed to counter the problem, experts have warned at an international forum.  …

GSK announces initial findings from real world COPD study

Initial results have been announced from the Salford Lung Study, a phase III clinical trial in which researchers sought to discover how a new combination treatment for chronic obstructive pulmonary disease fared against traditional therapy in a real world setting.…

Chemotherapy dose banding to be rolled out across England

NHS England has announced plans to implement chemotherapy dose banding nationwide. …

Scottish Pharmacy Board election 2016 result

The final counting of votes for the Royal Pharmaceutical Society election 2016 took place immediately following the close of poll at 12pm on the 27 May 2016. A breakdown of the result and turnout for Scotland is included below: Electorate   Number of individuals…